US FDA warns of injection-site reactions with naltrexone

被引:0
|
作者
机构
关键词
Public Health; Healthcare Professional; Injection Site; Naltrexone; Cellulitis;
D O I
10.2165/00128415-200812160-00009
中图分类号
学科分类号
摘要
引用
收藏
页码:5 / 5
相关论文
共 50 条
  • [1] POSTIMMUNIZATION (VACCINATION) INJECTION-SITE REACTIONS
    STRINGFELLOW, HF
    HOWAT, AJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (11) : 1179 - 1180
  • [2] Tralokinumab-induced injection-site reactions
    De Greef, Axel
    Baeck, Marie
    [J]. CONTACT DERMATITIS, 2024,
  • [3] POSTIMMUNIZATION (VACCINATION) INJECTION-SITE REACTIONS - REPLY
    MILIAUSKAS, J
    MUKHERJEE, T
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (11) : 1180 - 1180
  • [6] Etanercept-associated injection-site reactions
    Murphy, FT
    Enzenauer, RJ
    Battafarano, DF
    David-Bajar, K
    [J]. ARCHIVES OF DERMATOLOGY, 2000, 136 (04) : 556 - 557
  • [7] A delayed injection-site reaction in a patient receiving extended-release naltrexone
    Ahamad, Keith
    Korthuis, P. Todd
    Lum, Paula J.
    Johnson, Cheyenne
    Wood, Evan
    [J]. SUBSTANCE ABUSE, 2016, 37 (02) : 278 - 280
  • [9] Recall Injection-Site Reactions After Treatment With Anakinra
    De Aramburu Mera, T.
    Reguero Capilla, M.
    Ochando Diez-Canseco, M.
    Prados Castano, M.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (03) : 275 - 276